Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

GDF15 secreted by senescent endothelial cells improves vascular progenitor cell functions.

Ha G, De Torres F, Arouche N, Benzoubir N, Ferratge S, Hatem E, Anginot A, Uzan G.

PLoS One. 2019 May 10;14(5):e0216602. doi: 10.1371/journal.pone.0216602. eCollection 2019.

2.

Autologous endothelial progenitor cell therapy improves right ventricular function in a model of chronic thromboembolic pulmonary hypertension.

Loisel F, Provost B, Guihaire J, Boulate D, Arouche N, Amsallem M, Arthur-Ataam J, Decante B, Dorfmüller P, Fadel E, Uzan G, Mercier O.

J Thorac Cardiovasc Surg. 2019 Feb;157(2):655-666.e7. doi: 10.1016/j.jtcvs.2018.08.083. Epub 2018 Sep 27.

PMID:
30669226
3.

Celastrol Reverses Palmitic Acid-Induced Insulin Resistance in HepG2 Cells via Restoring the miR-223 and GLUT4 Pathway.

Zhang X, Xue XC, Wang Y, Cao FF, You J, Uzan G, Peng B, Zhang DH.

Can J Diabetes. 2019 Apr;43(3):165-172. doi: 10.1016/j.jcjd.2018.07.002. Epub 2018 Jul 17.

PMID:
30287053
4.

Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance.

Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D.

Anticancer Drugs. 2018 Sep;29(8):748-755. doi: 10.1097/CAD.0000000000000647.

PMID:
29927769
5.

Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA.

Zhang X, Wang Y, Ge HY, Gu YJ, Cao FF, Yang CX, Uzan G, Peng B, Zhang DH.

J Cell Physiol. 2018 Oct;233(10):6814-6824. doi: 10.1002/jcp.26547. Epub 2018 Apr 18.

PMID:
29667734
6.

Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

Loisel F, Provost B, Haddad F, Guihaire J, Amsallem M, Vrtovec B, Fadel E, Uzan G, Mercier O.

Pulm Circ. 2018 Apr-Jun;8(2):2045893218755979. doi: 10.1177/2045893218755979. Epub 2018 Feb 26.

7.

What should be the appropriate minimal duration for patient examination and evaluation in pulmonary outpatient clinics?

Musellim B, Borekci S, Uzan G, Ali Sak ZH, Ozdemir SK, Altinisik G, Altunbey SA, Sen N, Kilinc O, Yorgancioglu A; Duration for Patient Examination Working Group of Turkish Thoracic Society.

Ann Thorac Med. 2017 Jul-Sep;12(3):177-182. doi: 10.4103/atm.ATM_396_16.

8.

Initial clonogenic potential of human endothelial progenitor cells is predictive of their further properties and establishes a functional hierarchy related to immaturity.

Ferratge S, Ha G, Carpentier G, Arouche N, Bascetin R, Muller L, Germain S, Uzan G.

Stem Cell Res. 2017 May;21:148-159. doi: 10.1016/j.scr.2017.04.009. Epub 2017 Apr 21.

9.

Circulating endothelial progenitors in vascular repair.

Ferratge S, Boyer J, Arouch N, Chevalier F, Uzan G.

Biomed Mater Eng. 2017;28(s1):S65-S74. doi: 10.3233/BME-171625.

PMID:
28372279
10.

Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.

Mu Z, Benali-Furet N, Uzan G, Znaty A, Ye Z, Paolillo C, Wang C, Austin L, Rossi G, Fortina P, Yang H, Cristofanilli M.

Int J Mol Sci. 2016 Sep 30;17(10). pii: E1665.

11.

Celastrol targets IRAKs to block Toll-like receptor 4-mediated nuclear factor-κB activation.

Shen YF, Zhang X, Wang Y, Cao FF, Uzan G, Peng B, Zhang DH.

J Integr Med. 2016 May;14(3):203-8. doi: 10.1016/S2095-4964(16)60257-1.

PMID:
27181127
12.

A Novel Molecular and Functional Stemness Signature Assessing Human Cord Blood-Derived Endothelial Progenitor Cell Immaturity.

Guillevic O, Ferratge S, Pascaud J, Driancourt C, Boyer-Di-Ponio J, Uzan G.

PLoS One. 2016 Apr 4;11(4):e0152993. doi: 10.1371/journal.pone.0152993. eCollection 2016.

13.

Transcatheter Arterial Infusion of Autologous CD133(+) Cells for Diabetic Peripheral Artery Disease.

Zhang X, Lian W, Lou W, Han S, Lu C, Zuo K, Su H, Xu J, Cao C, Tang T, Jia Z, Jin T, Uzan G, Gu J, Li M.

Stem Cells Int. 2016;2016:6925357. doi: 10.1155/2016/6925357. Epub 2016 Feb 14.

14.

Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.

Cao L, Zhang X, Cao F, Wang Y, Shen Y, Yang C, Uzan G, Peng B, Zhang D.

BMC Cancer. 2015 Nov 9;15:873. doi: 10.1186/s12885-015-1909-2.

15.

Tripterine treatment improves endothelial progenitor cell function via integrin-linked kinase.

Lu C, Yu X, Zuo K, Zhang X, Cao C, Xu J, Wang S, Tang T, Ye M, Pei E, Uzan G, Zhi K, Li M.

Cell Physiol Biochem. 2015;37(3):1089-103. doi: 10.1159/000430234. Epub 2015 Sep 23.

16.

A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy?

Chevalier F, Arnaud D, Henault E, Guillevic O, Siñeriz F, Ponsen AC, Papy-Garcia D, Barritault D, Letourneur D, Uzan G, Meddahi-Pellé A, Hlawaty H, Albanese P.

Eur Cell Mater. 2015 Sep 4;30:51-68.

17.

Compte rendu de la séance dédiée à L'utilisation des cellules mésenchymateuses (CSM) en médecine régénératrice.

Caen J, Uzan G.

Bull Acad Natl Med. 2015 Apr-May;199(4-5):525-7. French. No abstract available.

PMID:
27509670
18.

Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.

Wang Y, Cao L, Xu LM, Cao FF, Peng B, Zhang X, Shen YF, Uzan G, Zhang DH.

J Neuroimmune Pharmacol. 2015 Sep;10(3):506-16. doi: 10.1007/s11481-015-9598-9. Epub 2015 Mar 15.

PMID:
25773257
19.

Endoderm generates endothelial cells during liver development.

Goldman O, Han S, Hamou W, Jodon de Villeroche V, Uzan G, Lickert H, Gouon-Evans V.

Stem Cell Reports. 2014 Oct 14;3(4):556-65. doi: 10.1016/j.stemcr.2014.08.009. Epub 2014 Sep 18.

20.

Short time tripterine treatment enhances endothelial progenitor cell function via heat shock protein 32.

Lu C, Zhang X, Zhang D, Pei E, Xu J, Tang T, Ye M, Uzan G, Zhi K, Li M, Zuo K.

J Cell Physiol. 2015 May;230(5):1139-47. doi: 10.1002/jcp.24849.

PMID:
25336054
21.

A fibrin antibody binding to fibronectin induces potent inhibition of angiogenesis.

El-Ayoubi F, Amiral J, Pascaud J, Charrin S, Tassel B, Uzan G, Gurewich V.

Thromb Haemost. 2015 Jan;113(1):143-53. doi: 10.1160/TH14-01-0020. Epub 2014 Sep 25.

PMID:
25252851
22.

Heterogeneous functions of perinatal mesenchymal stromal cells require a preselection before their banking for clinical use.

Peltzer J, Montespan F, Thepenier C, Boutin L, Uzan G, Rouas-Freiss N, Lataillade JJ.

Stem Cells Dev. 2015 Feb 1;24(3):329-44. doi: 10.1089/scd.2014.0327. Epub 2014 Oct 21.

PMID:
25203666
23.

Celastrol inhibits lung infiltration in differential syndrome animal models by reducing TNF-α and ICAM-1 levels while preserving differentiation in ATRA-induced acute promyelocytic leukemia cells.

Xu LM, Zheng YJ, Wang Y, Yang Y, Cao FF, Peng B, Xu XF, An HZ, Zheng AX, Zhang DH, Uzan G, Yu YZ.

PLoS One. 2014 Aug 12;9(8):e105131. doi: 10.1371/journal.pone.0105131. eCollection 2014.

24.

Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate.

Negroni E, Henault E, Chevalier F, Gilbert-Sirieix M, Van Kuppevelt TH, Papy-Garcia D, Uzan G, Albanese P.

J Neuropathol Exp Neurol. 2014 Aug;73(8):789-97. doi: 10.1097/NEN.0000000000000098.

PMID:
25003237
25.

Glycosaminoglycan mimetic improves enrichment and cell functions of human endothelial progenitor cell colonies.

Chevalier F, Lavergne M, Negroni E, Ferratge S, Carpentier G, Gilbert-Sirieix M, Siñeriz F, Uzan G, Albanese P.

Stem Cell Res. 2014 May;12(3):703-15. doi: 10.1016/j.scr.2014.03.001. Epub 2014 Mar 10.

26.

Peptide deformylase inhibitor actinonin reduces celastrol's HSP70 induction while synergizing proliferation inhibition in tumor cells.

Peng B, Zhang X, Cao F, Wang Y, Xu L, Cao L, Yang C, Li M, Uzan G, Zhang D.

BMC Cancer. 2014 Mar 4;14:146. doi: 10.1186/1471-2407-14-146.

27.

Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes.

Boyer-Di Ponio J, El-Ayoubi F, Glacial F, Ganeshamoorthy K, Driancourt C, Godet M, Perrière N, Guillevic O, Couraud PO, Uzan G.

PLoS One. 2014 Jan 2;9(1):e84179. doi: 10.1371/journal.pone.0084179. eCollection 2014.

28.

EPCs in vascular repair: how can we clear the hurdles between bench and bedside?

Lu C, Zhang J, Zhang D, Uzan G, Li M.

Front Biosci (Landmark Ed). 2014 Jan 1;19:34-48. Review.

PMID:
24389171
29.

IP-FCM platform detects the existence and regulator-caused dissociation of components in naturally assembled HSP90 complex.

Cao FF, Xu LM, Zhang X, Wang Y, Li MQ, Uzan G, Peng B, Zhang DH.

Cytometry A. 2014 Apr;85(4):359-67. doi: 10.1002/cyto.a.22421. Epub 2013 Nov 21.

30.

Toll-like receptor 3 regulates cord blood-derived endothelial cell function in vitro and in vivo.

Grelier A, Cras A, Balitrand N, Delmau C, Lecourt S, Lepelletier Y, Riesterer H, Freida D, Lataillade JJ, Lebousse-Kerdiles MC, Cuccini W, Peffault de Latour R, Marolleau JP, Uzan G, Larghero J, Vanneaux V.

Angiogenesis. 2013 Oct;16(4):821-36. doi: 10.1007/s10456-013-9358-5. Epub 2013 Jun 8.

PMID:
23748743
31.

[Method of expansion of late endothelial progenitor cells].

Wu LH, Song ZX, Liu XH, Li SZ, Han ZC, Uzan G.

Zhonghua Yi Xue Za Zhi. 2012 Sep 25;92(36):2574-7. Chinese.

PMID:
23158802
32.

Role of microenvironment in the process of expansion of late endothelial progenitor cell in vitro.

Wu LH, Song ZX, Liu XH, Li SZ, Han ZC, Uzan G.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Jun;34(3):202-6. doi: 10.3881/j.issn.1000-503X.2012.03.002.

33.

Porous polysaccharide-based scaffolds for human endothelial progenitor cells.

Lavergne M, Derkaoui M, Delmau C, Letourneur D, Uzan G, Le Visage C.

Macromol Biosci. 2012 Jul;12(7):901-10. doi: 10.1002/mabi.201100431. Epub 2012 Jun 13.

PMID:
22696505
34.

Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis.

Avouac J, Meune C, Ruiz B, Couraud PO, Uzan G, Boileau C, Kahan A, Chiocchia G, Allanore Y.

Ann Rheum Dis. 2012 Mar;71(3):394-9. doi: 10.1136/annrheumdis-2011-200143. Epub 2011 Nov 15.

PMID:
22085793
35.

Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.

Avouac J, Cagnard N, Distler JH, Schoindre Y, Ruiz B, Couraud PO, Uzan G, Boileau C, Chiocchia G, Allanore Y.

Arthritis Rheum. 2011 Nov;63(11):3552-62. doi: 10.1002/art.30536.

36.

An overview of the progress on double umbilical cord blood transplantation.

Sideri A, Neokleous N, Brunet De La Grange P, Guerton B, Le Bousse Kerdilles MC, Uzan G, Peste-Tsilimidos C, Gluckman E.

Haematologica. 2011 Aug;96(8):1213-20. doi: 10.3324/haematol.2010.038836. Epub 2011 May 5. Review.

37.

Cord blood-circulating endothelial progenitors for treatment of vascular diseases.

Lavergne M, Vanneaux V, Delmau C, Gluckman E, Rodde-Astier I, Larghero J, Uzan G.

Cell Prolif. 2011 Apr;44 Suppl 1:44-7. doi: 10.1111/j.1365-2184.2010.00722.x.

PMID:
21481043
38.

Identification of new markers discriminating between myeloid and lymphoid acute leukemia.

Haouas H, Haouas S, Uzan G, Hafsia A.

Hematology. 2010 Aug;15(4):193-203. doi: 10.1179/102453310X12647083620769.

PMID:
20670477
39.

[Are stem cells as old as their niches? The quest for eternal life...].

Lataillade JJ, Brunet de la Grange P, Uzan G, Le Bousse-Kerdilès MC.

Med Sci (Paris). 2010 Jun-Jul;26(6-7):582-5. doi: 10.1051/medsci/2010266-7582. French. No abstract available.

40.

Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way.

Zhang D, Xu L, Cao F, Wei T, Yang C, Uzan G, Peng B.

Cell Stress Chaperones. 2010 Nov;15(6):939-46. doi: 10.1007/s12192-010-0202-1. Epub 2010 May 18.

41.

[Implication of hyaluronic acid in normal and pathological angiogenesis. Application for cellular engineering].

Lataillade JJ, Albanese P, Uzan G.

Ann Dermatol Venereol. 2010 Apr;137 Suppl 1:S15-22. doi: 10.1016/S0151-9638(10)70004-1. Review. French.

PMID:
20435250
42.

In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: are we ready for clinical application?

Vanneaux V, El-Ayoubi F, Delmau C, Driancourt C, Lecourt S, Grelier A, Cras A, Cuccuini W, Soulier J, Lataillade JJ, Lebousse-Kerdiles MC, Oury JF, Sibony O, Marolleau JP, Benbunan M, Uzan G, Larghero J.

Cell Transplant. 2010;19(9):1143-55. doi: 10.3727/096368910X504487. Epub 2010 May 4.

PMID:
20447337
43.

HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way.

Peng B, Xu L, Cao F, Wei T, Yang C, Uzan G, Zhang D.

Mol Cancer. 2010 Apr 16;9:79. doi: 10.1186/1476-4598-9-79.

44.

Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity.

Jodon de Villeroché V, Avouac J, Ponceau A, Ruiz B, Kahan A, Boileau C, Uzan G, Allanore Y.

Arthritis Res Ther. 2010;12(1):R27. doi: 10.1186/ar2934. Epub 2010 Feb 16.

45.

[Cord blood circulating endothelial progenitors: perspectives for clinical use in cardiovascular diseases].

Uzan G, Vanneaux V, Delmau C, Ayoubi F, Gluckman E, Larghero J.

Bull Acad Natl Med. 2009 Mar;193(3):537-43; discussion 543-4. French.

PMID:
19883008
46.

A routinely applicable way for using FCM in cell enumeration with CFSE-labeled CellBeads as internal standard.

Cao FF, Xu LM, Peng B, Xie QH, Uzan G, Zhang DH.

Cytometry A. 2009 Dec;75(12):975-8. doi: 10.1002/cyto.a.20809. No abstract available.

47.

The role of HGF on invasive properties and repopulation potential of human fetal hepatic progenitor cells.

Delgado JP, Vanneaux V, Branger J, Touboul T, Sentilhes L, Mainot S, Lainas P, Leclerc P, Uzan G, Mahieu-Caputo D, Weber A.

Exp Cell Res. 2009 Nov 15;315(19):3396-405. doi: 10.1016/j.yexcr.2009.07.007. Epub 2009 Jul 15.

PMID:
19615360
48.

A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage.

Goldman O, Feraud O, Boyer-Di Ponio J, Driancourt C, Clay D, Le Bousse-Kerdiles MC, Bennaceur-Griscelli A, Uzan G.

Stem Cells. 2009 Aug;27(8):1750-9. doi: 10.1002/stem.100.

49.

Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights.

Albanese P, Caruelle D, Frescaline G, Delbé J, Petit-Cocault L, Huet E, Charnaux N, Uzan G, Papy-Garcia D, Courty J.

Exp Hematol. 2009 Sep;37(9):1072-83. doi: 10.1016/j.exphem.2009.06.005. Epub 2009 Jun 17.

PMID:
19539688
50.

Impact of age and gender interaction on circulating endothelial progenitor cells in healthy subjects.

Rousseau A, Ayoubi F, Deveaux C, Charbit B, Delmau C, Christin-Maitre S, Jaillon P, Uzan G, Simon T.

Fertil Steril. 2010 Feb;93(3):843-6. doi: 10.1016/j.fertnstert.2008.10.062. Epub 2008 Dec 25.

PMID:
19111297

Supplemental Content

Support Center